Former X CEO Linda Yaccarino has been tapped as the new CEO of eMed Population Health, an AI‑driven health tech startup.

Yaccarino, who has a house in Woodbury, graduated from Deer Park High in 1981 with her twin sister, Lori. Both were elected ...

Even though Novo Nordisk warned that copycat versions of its obesity and diabetes drugs would hurt sales in the U.S., second-quarter sales saw a 67% rise year on year. More news covers telehealth ...

There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that ...

In today’s health headlines, the importance of culinary medicine teachings for medical residents, childhood vaccination rates have dropped again, and why weather changes impact how you feel. Dr. Arjun ...

President Trump threatened 250% tariffs on pharma; Pfizer CEO contacted Trump about most favored nation pricing; Ex-X CEO joins eMed.

Yaccarino will be CEO of a unit at the company, which focuses on patients taking weight-management and diabetes medications.

Yaccarino has been named CEO of Miami-based eMed Population Health, which calls itself “the leading digital health platform ...

Linda Yaccarino, the former X CEO who left the social media company in the wake of yet another Elon Musk controversy, has ...

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators ...

Government plans to tackle problem drinking “are not sufficient to address the scale and complexity of harm”, leading health experts have warned. Academics, medics and charities from around the ...

Hims & Hers Health posted an increase in profit and revenue for the second quarter on growth in subscribers using personalized treatment plans. The telehealth-consultation platform on Monday posted a ...